Listen "After the Storm: Why MDMA Assisted Therapy Still Matters"
Episode Synopsis
Dr. Chantelle Thomas and Dr. Evan Sola discuss the implications of the FDA's decision not to approve MDMA for PTSD treatment, emphasizing the nuances of the MDMA-assisted therapy model. They highlight ongoing clinical trials, including those at the Portland VA and UCLA, and the importance of accurate public and therapist education. Dr. Sola shares his experience with severe PTSD patients and the relational aspects of therapy, stressing the need for humility and supervision. They address misconceptions about the model, advocating for a non-pathologizing, participant-led approach that values the therapist's role in validating and supporting the client's process. (0:00:33) Introduction (0:07:30) Evan Sola and His Work (0:18:13) Discussion on Public Perception and Therapist Education (0:29:37) Challenges and Misrepresentations of the MDMA-Assisted Therapy Model (1:11:45) The Importance of Relationality and Organicity in Therapy Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/ Frontier article: https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2024.1427531/full Integrata: www.integratahealing.com Evan Sola, PSYD: https://www.evansolapsyd.com/ Lykos: https://lykospbc.com
More episodes of the podcast Blind Spots: Exploring What We Cannot See
Frog and Toad Do Ketamine
04/10/2025
Expanding Access to (Psychedelic) Care
13/09/2024
Therapy Unblinded: Inside MDMA Research
26/06/2024
KAP: Undissociating into Feeling
18/03/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.